XML 89 R74.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-Based Compensation -Shares of Stock Outstanding (Details)
shares in Thousands
12 Months Ended
Jan. 30, 2016
$ / shares
shares
Restricted Stock Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares  
Beginning balance, Outstanding (in shares) | shares 398
Granted (in shares) | shares 795
Vested (in shares) | shares (409)
Cancelled (in shares) | shares (153)
Ending balance, Outstanding (in shares) | shares 631
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value  
Beginning balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 4.60
Granted, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 3.14
Vested, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 4.33
Cancelled, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 3.16
Ending balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 3.28
Cash-Settled Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares  
Beginning balance, Outstanding (in shares) | shares 747
Granted (in shares) | shares 0
Vested (in shares) | shares (101)
Cancelled (in shares) | shares (178)
Ending balance, Outstanding (in shares) | shares 468
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value  
Beginning balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 2.44
Granted, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 0.00
Vested, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 1.80
Cancelled, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 1.42
Ending balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 0.26
Non-vested stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares  
Beginning balance, Outstanding (in shares) | shares 1,451
Granted (in shares) | shares 446
Vested (in shares) | shares (931)
Cancelled (in shares) | shares (249)
Ending balance, Outstanding (in shares) | shares 717
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value  
Beginning balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 11.61
Granted, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 2.88
Vested, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 10.63
Cancelled, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 10.84
Ending balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 7.72
Performance-Based Performance Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares  
Beginning balance, Outstanding (in shares) | shares 0
Granted (in shares) | shares 0
Vested (in shares) | shares 0
Cancelled (in shares) | shares 0
Ending balance, Outstanding (in shares) | shares 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value  
Beginning balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 0.00
Granted, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 0.00
Vested, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 0.00
Cancelled, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 0.00
Ending balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 0.00
Market-based Performance Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares  
Beginning balance, Outstanding (in shares) | shares 489
Granted (in shares) | shares 0
Vested (in shares) | shares 0
Cancelled (in shares) | shares (269)
Ending balance, Outstanding (in shares) | shares 220
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value  
Beginning balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 10.25
Granted, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 0.00
Vested, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 0.00
Cancelled, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares 10.74
Ending balance, Outstanding, Weighted Average Grant-Date Fair Value (usd per share) | $ / shares $ 9.65